Evidence map›Paper›PMID 28886345›Full record

ArticleAmerican journal of human genetics2017

RAC1 Missense Mutations in Developmental Disorders with Diverse Phenotypes.

Margot R F Reijnders, Nurhuda M Ansor, Maria Kousi, Wyatt W Yue, Perciliz L Tan, Katie Clarkson, Jill Clayton-Smith, Ken Corning, Julie R Jones, Wayne W K Lam and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 164 citations in OpenAlex.

  1. Review
  2. The role of Rho GTPases in facial morphogenesis.Developmental dynamics : an official publication of the American Association of Anatomists · 2026
    Review
  3. Article
  4. A matter of switch: how RAC1 variants drive distinct disorders.European journal of human genetics : EJHG · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. ARP2/3 complex mediates the neuropathology of PTEN-deficient human neural cells downstream of mTORC1 and mTORC2 hyperactivation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Genes Co-Expressed withInternational journal of molecular sciences · 2024
    Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 12 institutions in 5 countries.

Margot R F ReijndersDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Nurhuda M AnsorDivision of Developmental Biology & Medicine, Faculty of Biology, Medicine and Health, University of Manchester M13 9PL, UK; Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, 13200 Kepala Batas, Penang, Malaysia.
Maria KousiCenter for Human Disease Modeling, Department of Cell Biology, Duke University, Durham, NC 27701, USA.
Wyatt W YueStructural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.
Perciliz L TanCenter for Human Disease Modeling, Department of Cell Biology, Duke University, Durham, NC 27701, USA.
Katie ClarksonGreenwood Genetic Center, Greenwood, SC 29646, USA.
Jill Clayton-SmithManchester Centre for Genomic Medicine, St. Mary's Hospital, Central Manchester NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester M13 9WL, UK; Division of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
Ken CorningGreenwood Genetic Center, Greenwood, SC 29646, USA.
Julie R JonesGreenwood Genetic Center, Greenwood, SC 29646, USA.
Wayne W K LamSouth East of Scotland Clinical Genetic Service, Western General Hospital, Edinburgh EH4 2XU, UK.
Grazia M S ManciniDepartment of Clinical Genetics, Erasmus Medical Center, 3000 CA Rotterdam, the Netherlands.
Carlo MarcelisDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Shehla MohammedDepartment of Clinical Genetics, Guy's and St Thomas' Hospital, London SE1 7EH, UK.
Rolph PfundtDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Maian RoifmanThe Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada; Division of Clinical and Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada.
Ronald CohnDivision of Clinical and Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada.
David ChitayatThe Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada; Division of Clinical and Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada.
Deciphering Developmental Disorders Study
Tom H MillardDivision of Developmental Biology & Medicine, Faculty of Biology, Medicine and Health, University of Manchester M13 9PL, UK.
Nicholas KatsanisCenter for Human Disease Modeling, Department of Cell Biology, Duke University, Durham, NC 27701, USA.
Han G BrunnerDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands; Department of Clinical Genetics and School for Oncology & Developmental Biology (GROW), Maastricht University Medical Center, 6202 AZ Maastricht, the Netherlands. Electronic address: han.brunner@radboudumc.nl.
Siddharth BankaManchester Centre for Genomic Medicine, St. Mary's Hospital, Central Manchester NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester M13 9WL, UK; Division of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK. Electronic address: siddharth.banka@manchester.ac.uk.
Radboud University Nijmegen · NLDuke University · USGreenwood Genetic Center · USManchester Academic Health Science Centre · GBMount Sinai Hospital · CAErasmus MC · NLSt Thomas' Hospital · GBUniversiti Sains Malaysia · MYUniversity of Manchester · GBUniversity of Oxford · GBUniversity of Toronto · CAWestern General Hospital · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

RAC1 is a widely studied Rho GTPase, a class of molecules that modulate numerous cellular functions essential for normal development. RAC1 is highly conserved across species and is under strict mutational constraint. We report seven individuals with distinct de novo missense RAC1 mutations and varying degrees of developmental delay, brain malformations, and additional phenotypes. Four individuals, each harboring one of c.53G>A (p.Cys18Tyr), c.116A>G (p.Asn39Ser), c.218C>T (p.Pro73Leu), and c.470G>A (p.Cys157Tyr) variants, were microcephalic, with head circumferences between -2.5 to -5 SD. In contrast, two individuals with c.151G>A (p.Val51Met) and c.151G>C (p.Val51Leu) alleles were macrocephalic with head circumferences of +4.16 and +4.5 SD. One individual harboring a c.190T>G (p.Tyr64Asp) allele had head circumference in the normal range. Collectively, we observed an extraordinary spread of ∼10 SD of head circumferences orchestrated by distinct mutations in the same gene. In silico modeling, mouse fibroblasts spreading assays, and in vivo overexpression assays using zebrafish as a surrogate model demonstrated that the p.Cys18Tyr and p.Asn39Ser RAC1 variants function as dominant-negative alleles and result in microcephaly, reduced neuronal proliferation, and cerebellar abnormalities in vivo. Conversely, the p.Tyr64Asp substitution is constitutively active. The remaining mutations are probably weakly dominant negative or their effects are context dependent. These findings highlight the importance of RAC1 in neuronal development. Along with TRIO and HACE1, a sub-category of rare developmental disorders is emerging with RAC1 as the central player. We show that ultra-rare disorders caused by private, non-recurrent missense mutations that result in varying phenotypes are challenging to dissect, but can be delineated through focused international collaboration.

Indexed as

Mutation, MissenseAdolescentAmino Acid SequenceAnimalsBrain DiseasesChildChild, PreschoolDevelopmental DisabilitiesEmbryo, NonmammalianFemaleHumansInfantMaleMiceMicrocephalyPedigreerac1 GTP-Binding ProteinRAC1 protein, humancerebellar abnormalitiesdevelopmental disordersHACE1intellectual disabilitymacrocephalymicrocephalyneuronal proliferationRAC1Rho GTPaseTRIO

Identifiers

PMID28886345
PMCPMC5591022
OpenAlexW2750793262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.